Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

Researchers say more study is needed, but early results suggest the century-old vaccine could become a powerful new tool in ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

“If someone does not take proper treatment for tuberculosis, it can ultimately lead to the death to the patient,” warns ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Recently, after years of pressure, advocates including author and philanthropist John Green scored victory against Johnson & Johnson over a patent on a key tuberculosis drug. The campaigners hope the ...

In mid-December 2024, a rumor circulated online that Canada was imprisoning citizens who refused to take government-mandated medication. Both X users included a screenshot of an article (archived) by ...